Figure 6. .

Impact of dexamethasone and bevacizumab on NF-κB signaling in IL-1β–induced angiogenesis. (A) Representative Western blots from IL-1β–implanted corneas for phospho-IκB and IκB, harvested on days 2, 4, and 6 (under reducing condition). N, untreated corneas; H, hydron-implanted corneas. (B) Representative Western blots of IL-1β–implanted corneas (day 3) for phospho-IκB and IκB with or without dexamethasone treatment (from day 2). (C) Representative Western blots of IgG- or bevacizumab-treated corneas (from day 2) on day 3 after IL-1β implantation for phospho-IκB and IκB.